This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

This study has been terminated.
(Low Recruitment)
Singapore Cancer Syndicate.
Information provided by:
Sidney Kimmel Comprehensive Cancer Center Identifier:
First received: October 2, 2007
Last updated: August 13, 2009
Last verified: August 2009

The proposal seeks to establish:

  • A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
  • A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
  • A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multidisciplinary knowledge, information and samples of its members.

Condition Intervention
Gastrointestinal Cancer Procedure: Blood drawing

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers

Further study details as provided by Sidney Kimmel Comprehensive Cancer Center:

Primary Outcome Measures:
  • there is no primary outcome measures in this study [ Time Frame: no time frame is provided ]

Estimated Enrollment: 60
Study Start Date: August 2007
Study Completion Date: July 2009
Groups/Cohorts Assigned Interventions
GI Cancer Procedure: Blood drawing
Once when enroll in study

  Show Detailed Description


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
GI cancer

Inclusion Criteria:

  • Patients with cancers of the gastrointestinal tract (eg. colorectal, gastric, pancreatic, esophageal)
  • Lower age limit: 18; Upper age limit: None



Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00539318

Johns Hopkins Singapore International Medical Centre
Singapore, Singapore, 308433
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
Singapore Cancer Syndicate.
Principal Investigator: Dr Alex Chang, MD JHS IMC
  More Information

Responsible Party: Alex Chang, Johns Hopkins Singapore International medical centre Identifier: NCT00539318     History of Changes
Other Study ID Numbers: JS0733
Study First Received: October 2, 2007
Last Updated: August 13, 2009

Additional relevant MeSH terms:
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases processed this record on August 16, 2017